Our results are corroborated by these previous studies that indicate a new approach to increasing the sensitivity of 68Ga-PSMA PET/CT for staging by administering ADT in patients with recurrent PCa and low PSA-levels. The gene discussed is FOLH1; the disease is posterior cortical atrophy.